Hypertension and heart failure : epidemiology, mechanisms and treatment / Maria Dorobantu, Giuseppe Mancia, Guido Grassi, Victor Voicu, editors.

Saved in:
Bibliographic Details
Online Access: Full Text (via Springer)
Other Authors: Dorobanţu, Maria (Editor), Mancia, Giuseppe (Editor), Grassi, Guido, 1954- (Editor), Voicu, Victor A. (Editor)
Format: eBook
Language:English
Published: Cham, Switzerland : Springer, 2019.
Series:Updates in hypertension and cardiovascular protection.
Subjects:
Table of Contents:
  • Intro; Preface; Contents; Part I: Epidemiological Aspects; 1: Epidemiological Aspects (Prevalence and Risk of Heart Failure Related to Blood Pressure); 1.1 Prevalence and Incidence of Heart Failure; 1.1.1 Heart Failure Definition and Classification; 1.1.2 Heart Failure Prevalence; 1.1.3 Incidence of Heart Failure; 1.1.4 Secular Trends in Heart Failure Epidemiology; 1.1.5 Heart Failure Epidemiology in Middle- and Low-Income Countries; 1.1.6 Mortality in Heart Failure; 1.2 Epidemiology of Hypertension and Heart Failure; 1.3 Conclusion; 1.4 Future Directions; References.
  • Part II: Mechanisms of Heart Failure in Arterial Hypertension2: Genetics of Hypertension and Heart Failure; 2.1 Heritability of Hypertension and Heart Failure; 2.2 Hypertension and Heart Failure: Causation; 2.3 Genetics of Hypertension and Heart Failure; 2.4 Genetic Pathways of Hypertension and Heart Failure; 2.4.1 Sodium and Intravascular Volume; 2.4.2 Autonomic Nervous System; 2.4.3 Cardiac and Vascular Mechanisms; 2.5 Future Directions; References; 3: Blood Pressure Variability and Blood Pressure Load; 3.1 Introduction; 3.2 Mechanisms; 3.3 Methods for Assessment of BPV.
  • 3.4 Indices for Estimation of BPV3.5 Clinical Relevance of BPV; 3.6 Blood Pressure Load; 3.7 Conclusions; References; 4: Hemodynamic Mechanisms; 4.1 Introduction; 4.2 LV Deformation; 4.2.1 Changes in LV Longitudinal Strain in Response to Increased Afterload; 4.2.2 Changes in LV Radial Strain in Response to Increased Afterload; 4.3 LV Remodeling; 4.4 LV End-Diastolic Filling Pressure (Diastolic Function); 4.5 The Correlation Network of BP and LV Traits; 4.6 Assessment of LV and Arterial Elastance.
  • 4.7 Area of the Pressure-Strain Loop During Ejection as Noninvasive Index of LV Performance4.8 Conclusion; References; 5: Neural Mechanisms; 5.1 Sympathetic Nervous System Activation in Human Hypertension; 5.2 Neural Reflexes in the Pathogenesis of Hypertension; 5.3 Interaction Between the Sympathetic Nervous System and the Renin-Angiotensin System; 5.4 Brain Neural Activity in Hypertension; 5.5 Heart Failure Attributable to Hypertension; 5.6 Role of Sympathetic Nervous System Activation in Heart Failure; 5.7 Role of the Kidney in the Pathophysiology of Heart Failure.
  • 5.8 Neural Reflexes in the Pathogenesis of Heart Failure5.9 Device-Based Therapeutic Interventions; 5.10 Renal Denervation in Hypertension; 5.11 Renal Denervation in Heart Failure; 5.12 Baroreflex Activation Therapy in Hypertension; 5.13 Baroreflex Activation Therapy in Heart Failure; 5.14 Carotid Body Denervation in Hypertension; 5.15 Carotid Body Denervation in Heart Failure; 5.16 Future Directions; References; 6: Natriuretic Peptides; 6.1 Introduction; 6.2 Natriuretic Peptides in HF; 6.2.1 Diagnostic Implications; 6.2.2 Prognostic Implications.